from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2809/-

LFCtreatmentdescriptionclass of inhibitor

0.176

Amikacinug/mL Amikacintranslation

0.591

Cap5-10ug/mL Capreomycintranslation

0.760

Rox10-50 ug/mL Roxithromycintranslation

-0.239

SM2-5 ug/mL Streptomycintranslation

1.470

Tet5-10 ug/mL Tetracyclinetranslation

0.822

Rif0.2-5ug/mL Rifampicintranscription

-0.019

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.090

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.922

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.076

CPZ10-50 ug/mL Chlorpromazinerespiration

0.714

Clofazimine10-13 ug/mL Clofaziminerespiration

0.055

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.640

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.173

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.190

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.103

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.505

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.110

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.029

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.708

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.312

KCN5-20 ug/mL Potassium cyaniderespiration

-0.942

NaN30.2-2 mM Sodium aziderespiration

-0.485

Nigericin50 uM Nigericinrespiration

0.098

TRC10-150 ug/mL Triclosanrespiration

1.338

TRZ10-25 ug/mL Thioridazinerespiration

0.576

Valinomycin0.5-10 uM Valinomycinrespiration

-1.236

ZnSO42 mM ZnSO4respiration

-0.996

menadione6-10 ug/mL Menadionerespiration

0.018

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.394

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.129

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.589

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.698

NRP_1Non-replicating persistence stage 1dosRassociated

-0.064

Amp0.2mg/mL AmpicillincellWall

-0.257

Cephalexin20-100 ug/mL CephalexincellWall

0.601

Cerulenin0.32-5 ug/mL CerulenincellWall

0.226

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.494

EMB10-20 ug/mL EthambutolcellWall

1.667

Eta12-40 ug/mL EthionamidecellWall

1.664

INH0.2-0.4 ug/mL IsoniazidcellWall

1.845

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.143

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.173

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.730

BZA0.12 mg/mL BenzamidearomaticAmides

-0.496

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.396

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.404

H2O24 mM hydrogen peroxideDNAdamaging

-0.177

Levo10 ug/mL LevofloxacinDNAdamaging

-0.434

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.140

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.072

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.271

UVUV-irradiationDNAdamaging

-0.294

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.091

Antimycin12.5-50 ug/mL Antimycin A?

-0.161

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.332

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.457

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.221

PA8240.2-2 ug/mL PA-824?

-0.475

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.177

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.047

Verapamil50 uM Verapamil?

0.124

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.399

methoxatin10-20 ug/mL Methoxatin?